The rationale behind the treatment is that because genetic FXI deficiency has been linked with reduced risk of ischemic ...

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

Some patients with an acute large-vessel ischemic stroke who already show a large-core infarct at early imaging can still benefit from thrombectomy, especially if the procedure successfully restores ...

Not all subtypes carry the same long-term cardiovascular risks, South Korean analysis show ...

THE age you first start smoking has a major effect on your risk of heart disease – more than the number of years you’ve ...

A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...

High-density lipoprotein cholesterol/low-density lipoprotein cholesterol (HDL-C/LDL-C) ratio of 0.4 to 0.6 was associated with a lower risk of myocardial infarction ...

The artery of Percheron (AOP) represents a rare anatomical variant whereby a single arterial trunk supplies both paramedian thalami and, in many cases, the rostral midbrain. Occlusion of this artery ...

Endovascular therapy for acute ischemic stroke is generally avoided when the infarction is large, but the effect of endovascular therapy with medical care as compared with medical care alone for large ...